Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dura and Spiros update joint development programs

Feb. 24, 1999

Janssen presents selective IL-5 production inhibitors for allergic and inflammatory disorders

Feb. 23, 1999

Serevent now available in Canada as a treatment for chronic obstructive pulmonary disease

Feb. 22, 1999

Structurally novel antiinflammatory/antiallergic agents in the Astra pipeline

Feb. 22, 1999

Potent bradykinin antagonists developed at Fournier

Feb. 19, 1999

FR-167653 compared to dexamethasone in acute lung inflammation

Feb. 18, 1999

PathoGenesis's CF treatment approved in Canada and Argentina

Feb. 17, 1999

S-5920 superior to methylprednisolone in protecting against ARDS

Feb. 17, 1999

Additional adverse reactions added to Flovent's package insert

Feb. 15, 1999

Inflazyme and HMR to collaborate on allergy, asthma and respiratory disease therapies

Feb. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...